Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns.

@article{Hoekstra2005EarlyGI,
  title={Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns.},
  author={James W. Hoekstra and Matthew T. Roe and Eric D. Peterson and Venu Menon and Jyotsna Mulgund and Charles V. Pollack and Chadwick D. Miller and Theresa M. Palabrica and Robert A. Harrington and E. Magnus Ohman and W. Brian Gibler},
  journal={Academic emergency medicine : official journal of the Society for Academic Emergency Medicine},
  year={2005},
  volume={12 5},
  pages={
          431-8
        }
}
OBJECTIVES The authors analyzed contemporary use of glycoprotein (GP) IIb/IIIa inhibitors in patients with non-ST-segment elevation acute coronary syndrome (NSTE ACS) to determine patient selection patterns with early (<24 hours) GP IIb/IIIa inhibitor use and the relationship between GP IIb/IIIa inhibitor therapy and use of other guidelines-recommended therapies for NSTE ACS. METHODS Using the CRUSADE Quality Improvement Initiative database, patient characteristics, in-hospital treatments… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Percutaneous coronary angioplasty in the elderly

Francesco Rengo, Tullio Niglio, +8 authors Federico Piscione
  • 2012